HDE supplement

H170001 S014: Minimally Invasive Deformity Correction (MID-C) System

FDA HDE supplement · normal 75 day track · ApiFix, Ltd.

Key facts

Original HDE H170001
Supplement number S014
Supplement type normal 75 day track
Reason for the supplement change design/components/specifications/material
Trade name Minimally Invasive Deformity Correction (MID-C) System
Generic name Posterior ratcheting rod system
Applicant ApiFix, Ltd.
Product code QGP
Received date Dec 23, 2021
Decision date Mar 1, 2022

At a glance

  • No Approval order on file

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About HDE supplements

An HDE supplement asks FDA to approve a change to a Humanitarian Use Device that already holds a humanitarian device exemption.

Source: U.S. Food and Drug Administration (FDA), Humanitarian Device Exemption (HDE) database · Source date:

Browse all HDE supplements